Last reviewed · How we verify

NCT05839431

Virtual Reality for Youth Phobias

Completed NA Last updated 19 July 2024
What this trial tests

NA trial testing Virtual Reality for Youth Phobias in Specific Phobia in 10 participants. Completed in 31 March 2024.

Timeline
14 July 2023
Primary endpoint
31 March 2024
31 March 2024

Quick facts

Lead sponsorUniversity of Miami
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date14 July 2023
Primary completion31 March 2024
Estimated completion31 March 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Miami

Who can join

8 and older, any sex, with Specific Phobia or Social Anxiety Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine the effectiveness of virtual reality (VR) delivered exposure therapy for youth with phobias or social anxiety, with and without autism spectrum disorder. The study team is also interested in collecting information to better understand phobias and social anxiety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Specific Phobia

Currently open trials in the same condition.

Other University of Miami trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05839431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing